Two Homeopathic Remedies Used Intermittently Provide Additional Protective Effects Against Hepatotoxicity Induced by Carcinogens in Mice

JAMS Journal of Acupuncture and Meridian Studies

Volumn 5, Issue 4, 2012, Pages 166-175

  Bhattacharjee, Nandini ^a   Khuda Bukhsh, Anisur Rahman ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Biomarkers; Combined therapy; Hepatocarcinogenesis; Homeopathy; Oxidative stress

Indexed keywords

4 DIMETHYLAMINOAZOBENZENE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CATALASE; CHOLESTERINUM; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; HOMEOPATHIC AGENT; LACTATE DEHYDROGENASE; MATRIX METALLOPROTEINASE; NATRUM SULPHURICUM; PHENOBARBITAL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HOMEOPATHY; LIPID PEROXIDATION; LIVER; LIVER TOXICITY; MALE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ZYMOGRAPHY;

EID: 84865183906     PISSN: 20052901     EISSN: 20938152     Source Type: Journal    
DOI: 10.1016/j.jams.2012.05.004     Document Type: Article

References (29)

1. Daoust R., Molnar F. Cellular populations and mitotic activity in rat liver parenchyma during azo dye carcinogenesis. Cancer Res 1964, 24:1898-1909.
2. Hirano T., Higashi K., Sakai A., Tsurudome Y., Ootsuyama Y., Kido R., et al. Analyses of oxidative DNA damage and its repair activity in the livers of 3'-methyl-4-dimethylaminoazobenzene-treated rodents. Jpn J Cancer Res 2000, 91:681-685.
3. Ohnishi S., Murata M., Degawa M., Kawanishi S. Oxidative DNA damage induced by an N-hydroxy metabolite of carcinogenic 4-dimethylaminoazobenzene. Jpn J Cancer Res 2001, 92:23-29.
4. Biswas S.J., Bhattacharjee N., Khuda-Bukhsh A.R. Efficacy of a plant extract (Chelidonium majus L.) in combating induced hepatocarcinogenesis in mice. Food Chem Toxicol 2008, 46:1474-1487.
5. International Agency for Research on Cancer (IARC Monographs) On the Evaluation of Carcinogenic Risk of Chemicals to Man, Group 2B 1987, (Suppl 7:)440.
6. International Agency for Research on Cancer (IARC Monographs) Summaries and Evaluations, Phenobarbital and its Sodium Salt, Group 2B 2001, 79. 161.
7. Pathak S., Khuda-Bukhsh A.R. Assessment of hepatocellular damage and hematological alterations in mice chronically fed p-dimethyl aminoazobenzene and phenobarbital. Exp Mol Pathol 2007, 83:104-111.
8. Pathak S., Das J.K., Biswas S.J., Khuda-Bukhsh A.R. Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice. Mol Cell Biochem 2006, 285:121-131.
9. Pathak S., Bhattacharjee N., Das J.K., Choudhury S.C., Karmakar S.R., Banerjee Pet., et al. Supportive evidence for anti-cancerous potential of an alternative medicine in hepatocarcinogenesis of mice. Forsch Komplementärmed 2007, 14:148-156.
10. Bhattacharjee N., Pathak S., Khuda-Bukhsh A.R. Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, Natrum Sulphuricum 200. Evid Based Complement Alternat Med 2009, 6:65-75.
11. Pathak S., Roy-Karmakar S., Banerjee A., Dutta S., Khuda-Bukhsh A.R. Combinational homeopathic therapy reduces genotoxicity and cytotoxicity in mice fed carcinogens. Clin Exp Homeopath 2009, 1:1.
12. Lockie A. The Family Guide to Homeopathy, the Safe Form of Medicine for the Future 1989, Penguin Books Ltd, England.
13. Boericke W. Pocket Manual of Homeopathic Materia Medica. Indian edn 1976, Sett Dey and Co., Calcutta, India.
14. Homeopathic Pharmacopoeia of India 1971, Ministry of Health, Government of India Press, Coimbatore-641019, Controller of Publications Delhi-110006. 1. 1st ed.
15. Bhattacharjee N., Banerjee P., Anisur R.K. Homeopathic drugs Natrum sulphuricum and Carcinosin prevent azo dye-induced hepatocarcinogenesis in mice. Indian J Biochem Biophys 2009, 46:307-318.
16. Billings P.C., Habres J.M., Liao D.C., Tuttle S.W. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 1991, 51:5539-5543.
17. Bain P.J., Latimer K.S., Mahaffey E.A., Prasse K.W. Duncan and prasse's veterinary medicine. Liver Clinical Pathology 2003, Iowa State Press, Ames, IA, 193-214. 4th ed.
18. Stockham S.L., Scott M.A. Fundamentals of Veterinary Clinical Pathology 2008, Iowa State Press, 610.
19. Vinitha R., Thangaraju M., Sachdanandam P. Effect of administering cyclophosphamide and vitamin E on the levels of tumor-marker enzymes in rats with experimentally induced fibrosarcoma. Jpn J Med Sci Biol 1995, 48:145-156.
20. Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999, 424:83-95.
21. Scandalios J.G. Oxidative stress: molecular perception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 2005, 38:995-1014.
22. Gerster H. Beta-carotene, vitamin E and vitamin C in different stages of experimental carcinogenesis. Eur J Clin Nutr 1995, 49:155-168.
23. Goldberg D.M., Spooner R.J. Glutathione reductase. Methods of Enzymatic Analysis 1987, 258-265. Verlag-Chemie, Weinheim. H.V. Bergmeyer (Ed.).
24. Khuda-Bukhsh A.R. Potentized homeopathic drugs act through regulation of gene-expression: a hypothesis to explain their mechanism and pathways of action in vivo. Complement Ther Med 1997, 5:43-46.
25. Khuda-Bukhsh A.R. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem 2003, 253:339-345.
26. Khuda-Bukhsh A.R. Laboratory Research in Homeopathy. Integr Cancer Ther 2006, 5:1-13.
27. Khuda-Bukhsh A.R. Mice as a model for homeopathy research. Homeopathy 2009, 98:267-279.
28. Bhattacharyya S.S., Mandal S.K., Biswas R., Paul S., Pathak S., Boujedaini N., et al. In vitro studies demonstrate anti-cancer activity of an alkaloid of the plant Gelsemium sempervirens. Exp Biol Med 2008, 233:1591-1601.
29. Molassiotis A., Panteli V., Patiraki E., Ozden G., Platin N., Madsen E., et al. Complementary and alternative medicine use in lung cancer patients in eight European countries. Complement Ther Clin Pract 2006, 12:34-39.